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ABSTRACT 
Purpose: To examine the possible role of H+-activated acid-sensing ion channels (ASICs) in pain 
perception we characterized their expression in bladder dome biopsies of Bladder Pain Syndrome 
(BPS) patients and controls, in cultured human urothelium and in urothelial TEU-2 cells.  
Materials and Methods: Cold cut biopsies from the bladder dome were obtained in 8 asymptomatic 
controls and 28 patients with symptoms of BPS.  ASIC expression was analyzed by QPCR and 
immunofluorescence. The channel function was measured by electrophysiology. 
Results: ASIC1a, ASIC2a and ASIC3 mRNAs were detected in human bladder. Similar amounts of 
ASIC1a and -3 were detected in detrusor smooth muscle, whereas in urothelium ASIC3 levels were 
higher than -1a. ASIC2a mRNA levels were lower than either -1a or -3 in both layers. ASIC currents 
were measured in TEU-2 cells and in primary cultures of human urothelium, and ASIC expression 
was confirmed by QPCR. Differentiation of TEU-2 cells caused an up-regulation of ASIC2a and 
ASIC3, and a down-regulation of ASIC1a mRNAs. BPS patients showed an up-regulation of ASIC2a 
and -3 mRNA, whereas ASIC1a remained unchanged. In contrast, the mRNA levels of TRPV1 were 
down-regulated during BPS. All differences were statistically significant (p<0.05) 
Conclusions: Several different ASIC subunits are expressed in human bladder and TEU-2 cells, where 
their levels are regulated during urothelial differentiation. An up-regulation of ASIC2a and -3 in BPS 
suggests their involvement in increased pain and hyperalgesia. A down-regulation of TRPV1 mRNA 
levels might indicate a different regulatory mechanism, controlling its expression in human bladder. 
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INTRODUCTION 
Bladder pain syndrome (BPS)/ interstitial cystitis (IC) is a clinical syndrome of pelvic pain, urgency 
and/or frequency without an identifiable cause, characterized by chronic inflammation. Tissue acidosis 
is a hallmark of inflammation and is thought to contribute to pain 1. Tissue acidosis is detected by 
channels which are gated or modulated by protons and capable of acid nociception. Acid-sensing ion 
channels (ASICs) are voltage-insensitive cation channels activated by extracellular protons. Functional 
ASICs are formed by homo- or heterotrimeric assembly of ASIC subunits 1a, 1b, 2a, 2b and/or 3 2. 
Expression of ASICs in nociceptive neurons and their activation by protons suggest a function as pain 
receptors, and several animal models provide an evidence for that 3,4. Most ASICs are transiently 
activated by pH changes in the physiological range, with pH of half-maximal activation values varying 
between 6.8 and 4.5, and activation thresholds as high as pH 7.0. Some ASIC isoforms display in 
addition to the transient also a small sustained component that lasts as long as the pH remains acidic 5. 
ASICs are present in dorsal root ganglion neurons 6, and in the central nervous system 7, as well as in 
vascular smooth muscle 8. The presence and function of ASICs in the bladder has been investigated in 
animal models. In mice, ASIC1 is the dominant ASIC subunit expressed in urothelium, whereas both 
ASIC1 and ASIC2 are expressed in bladder smooth muscle. ASIC3 expression is less abundant, and 
this subunit has been localized to the sub-epithelial region  9. Using QPCR, the presence of ASIC1, -2 
and -3 was confirmed in rat DRG, detrusor and mucosal tissues  10.  
Although ASICs have been implicated in bladder nociception, human data are scarce. BPS patients 
often report worsening of their symptoms and increased pain perception following ingestion of 
products which acidify urine 11,12. A recent study addressed the role of ASICs in experimentally-
induced cystitis in rats treated with cyclophosphamide (CYP) 13, providing the first evidence for ASIC 
up-regulation in the bladder during inflammation.  CYP-induced cystitis is a widely accepted animal 
model of this condition. However it is important to assess the disease-mediated changes of ASIC 
expression in humans with chronic BPS. We studied the expression levels of three ASIC transcripts 
(ASIC1a, ASIC2a, and ASIC3) in the layers of healthy human bladder. We functionally 
characterized these channels in human primary UE cultures and the immortalized urothelial cell 
line TEU-2 14. We investigated the presence of ASICs, and measured ASIC-mediated currents as 
well as differentiation-induced changes of ASIC gene expression.  
The transient receptor potential vanilloid 1 (TRPV1) channel, which is activated by chemical, 
mechanical and thermal stimuli including noxious heat (T>43°C), acid (pH ≤ 6) and capsaicin, is a 
putative acid sensor in the bladder. In bladder dysfunction TRPV1 has been shown to regulate the 
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frequency of bladder reflex contractions in chronically inflamed rat bladders 15 and be essential for 
cystitis-induced mechanical hyper-reactivity, though not involved in the cystitis development 16. 
Although different functional TRPs have been detected in cultured rodent urothelial cells 17, and 
TRPV1 immunoreactivity has also been reported in the human detrusor 18, the  presence of  functional 
TRPV1 in urothelial cells might be species-specific 19,20. In order to investigate the possible role of 
both types of channels in bladder pain, we examined the expression levels of the 3 most important 
ASIC subunits and TRPV1 in BPS patients, and compared them to the controls.  
 
MATERIALS AND METHODS 
Subjects   
Permission to conduct this study was obtained from the Ethics Committee of the Canton of Bern (KEK 
146/05), and all subjects gave written informed consent. Patient selection and evaluation was done as 
described previously 21. Patients were divided in 2 groups:  
1) Controls - asymptomatic patients undergoing cystoscopy for other reasons (e.g. stent placement for 
stone disease, microhematuria evaluation).  
2) BPS – patients with pain (> 3 months) considered to be located in the bladder and/or frequency, 
urgency and nocturia.  
Cold cut biopsies from the bladder dome were collected from 8 controls and 28 BPS patients. The 
biopsies were preserved in RNAlater (Qiagen) and stored at -70°C until RNA isolation. For 
morphological studies, samples from the dome were obtained from 4 patients (3 female and 1 male, 
mean age 65 years, range 52-74) undergoing radical cystectomy for bladder cancer, who had no lower 
urinary tract symptoms aside from hematuria.  
Cell culture 
Primary cultures of bladder smooth muscle and urothelium were established and maintained as 
described previously 21. The immortalized human urothelial cell line (TEU-2) 22 was maintained in 
serum-free EpiLife Medium supplemented with Human Keratinocyte Growth supplement (HKGS) and 
antibiotics (Cascade Biologics). Differentiation of TEU-2 cells was achieved by addition of serum and 
Ca2+ as previously described 23.  
Total RNA isolation, reverse transcription and real-time PCR analysis of mRNA expression 
Total RNA isolated as described previously 21. In order to separate bladder urothelium from the 
underlying stroma, post-operative tissue was treated with 5 mg/ml of dispase II overnight at 4oC. The 
reverse transcription reactions were carried out using the High Capacity cDNA Reverse Transcription 
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Kit (Applied Biosystems) with random hexamer primers. TRPV1 TaqMan primer (Hs00218912_m1) 
for QPCR was from Applied Biosystems. The ASIC primers for SYBR-Green QPCR were designed by 
using PrimerBLAST software and synthesized by Microsynth (Switzerland). The following primer 
pairs were used (all based on human sequences): 28S rRNA (endogenous control) forward 5’ 
TCTGACTTAGAGGCGTTCAGT CATAAT 3’, reverse 5’ 
GTTGTTGCCATGGTAATCCTGCTCAGT3’; ASIC1a forward 5’ ACC TGTATCATGCTGGGGAG 
3’, reverse 5’ TGCTTTTCATCTGCCATCTG 3’; ASIC2a forward 5’ 
CCACATCTTCGTGTATGGGC 3’, reverse 5’ CCTCTCAGAGCTCTCCACCA 3’; ASIC3 forward 
5’ AGAGGGTGCGCTACTACA GG 3’, reverse 5’ TTGATGTTGCACAGGGTGAC 3’; TRPV1+1b 
forward 5'GGACTCGGTGGGCAACACGG 3', reverse 5' CAGCTTCAGCGTCGGGTGCAG 
3'; TRPV1 long isoform (exon 7-specific) forward 5' AGCGGGAGATCCAGGAGCCC 3', 
reverse 5' AGGGGTCTCGCTGCTGCTGT 3'.   SYBR-Green quantitative real-time PCR (QPCR) 
was carried out in triplicates using 7900HT Fast Real-time PCR System (Applied Biosystems). The Ct 
values obtained after the real time-QPCR were normalized to the 18S housekeeping gene when 
performing TaqMan QPCR and to the 28S housekeeping gene when performing SYBR-Green QPCR.  
Tissue sections and immunofluorescence labeling 
Ultracryomicrotomy and immunohistochemistry were performed as previously described 21. Rabbit 
polyclonal anti-ASIC1 antibodies 24, recognizing the C-terminus common to ASIC1a and -1b were a 
kind gift from J.A.Wemmie, mouse monoclonal anti-SM α-actin antibody IA4 was from Sigma. Tissue 
sections were examined at Axiovert 200 M microscope with laser scanning module LSM 510 META 
(Zeiss).  
Electrophysiology 
Electrophysiological measurements and analyses were carried out with an EPC10 patch-clamp 
amplifier (HEKA Electronics, Lambrecht, Germany) HEKA’s Patchmaster and Fitmaster software. 
Experiments were carried out with the whole-cell patch-clamp technique at a holding potential of -60 
mV. Fast solution exchange (~100 ms) was achieved using the cF-8VS computer-controlled electro 
valve assembly and the MPRE8 perfusion system (Cell MicroControls, Norfolk, VA, USA). Pipettes 
were pulled from borosilicate glass (World Precision Instruments, Stevenage, UK) and had resistance 
between 2 and 4 MΩ when filled with the pipette solution. Pipette solutions contained (in mM) 90 
CsOH, 90 Gluconic Acid, 10 NaCl, 10 KCl, 1 MgCl2, 60 Hepes, 10 EGTA; pH adjusted to 7.3 with 
CsOH. Extracellular solutions contained (in mM) 140 NaCl, 4 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, 10 
MES, 10 glucose; pH adjusted to the desired value using NaOH or HCl. Amiloride was added from 5 
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mM stock solution in water. Chemicals were obtained from Acros Organics (Geel, Belgium), 
Applichem (Darmstadt, Germany), and Sigma or Fluka (Buchs, Switzerland). Data are presented 
as mean ± SEM. 
Statistical and data analysis 
In patients' studies the normality was defined with Kolmogorov-Smirnov and Shapiro-Wilk tests (p < 
0.05). Statistically significant differences were determined with a Mann Whitney U test with an α set to 
0.05 for genes not displaying a normal distribution, and with a two-tailed Student’s t-test, preceded by 
a Levene’s test, with an α set to 0.05 for genes with a normal distribution. The results of cell assays 
were analyzed using one-way ANOVA followed by Tukey's multiple comparison test. All studies were 
carried out with the SPSS program (version 17.0). 
ASIC pH dependence of activation curves was fitted with the following Hill equation: 
I=Imax/(1+(10-pH0.5/10-pH)nH) where Imax is the maximal current, pH0.5 is the pH of half maximal 
activation and nH he Hill number. ASIC inactivation kinetics were fitted with the following 
equation: I=I0*exp(-t/τ i) where I0 is the peak current, t the time and τ i the time constant of 
inactivation. 
 
RESULTS 
Expression of ASIC mRNAs in different layers of the human bladder and in cultured smooth muscle 
and urothelium cells  
In bladder samples obtained after cystectomies from patients without lower urinary tract symptoms, the 
urothelium layer was separated from the underlying stroma by enzymatic digestion followed by RNA 
isolation. The purity of urothelial samples was confirmed by QPCR using urothelium (UE)- and 
smooth muscle (SM)-specific markers as described previously 21. Uroplakin UPII was only detected in 
urothelium, whereas transgelin SM22 was only amplified in the stroma samples (Fig. 1). ASIC1a, -2a 
and -3 mRNAs were detected in urothelium and sub-urothelial stroma (Fig. 2A). In stroma there were 
no differences in the expression levels of ASIC3 and ASIC1a, whereas mRNA levels of ASIC2a were 
significantly lower (p < 0.05) (Table 1). ASIC1a was significantly more abundant in the stroma than in 
the isolated urothelium (Fig. 2A).  
All studied ASIC types were detected in primary cultures of UE and SM, however with a lower relative 
abundance than in the total bladder samples (Table 1). In contrast to bladder tissue, the differences in 
expression levels of ASICs between UE- and SM-primary cultures were not statistically significant 
(Fig. 2B).  
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Immunofluorescence detection of ASIC1 in healthy human bladder 
Using immunofluorescence labeling of ultrathin cryosections, we observed a modest labeling of the 
urothelium cell layer with anti-ASIC1 antibodies (Fig. 2, upper panels). In contrast, the detrusor 
smooth muscle showed a strong staining, which fully co-localized with SM α-actin-specific 
monoclonal antibody (Fig. 3, lower panels). We restricted our analysis of ASIC protein expression to 
ASIC1, because the commercially available antibodies for ASIC2 and ASIC3 that we had tested did not 
show specific staining when used in immunofluorescence labeling of dorsal root ganglion neurons of 
ASIC2 and -3 knockout mice, respectively (data not shown).  
ASIC expression and function in the TEU-2 urothelial cell line and in cultured human UE cells 
During differentiation of TEU-2 cells we observed a re-localization of the tight junction (TJ) protein 
occludin from the cytoplasm to the plasma membrane of the apical cells (Fig. 4A), and a concomitant 
increase in transepithelial electrical resistance, indicating the formation of a tight epithelium (not 
shown). We readily detected ASIC1a, and -3 by QPCR in TEU-2 monolayers, whereas the levels of 
ASIC2a were very low (Table 1). ASIC1a mRNA was significantly more abundant (p < 0.05) than 
ASIC3 or -2a in undifferentiated TEU-2 (Table 1). We measured mRNA levels of ASICs in TEU-2 
cells after 24, 48 and 72 h in differentiation medium, and observed a significant (p < 0.05) up-
regulation of ASIC2a and ASIC3 mRNA (Fig. 4B). In contrast, the levels of ASIC1a were reduced (p < 
0.05) during the differentiation process (Fig.4B). Following 72 h differentiation, the mRNA levels of 
ASIC3 became significantly (p < 0.05) higher than those of ASIC1a, whereas the relative abundance of 
ASIC2a remained the lowest of the studied transcripts (Table 1).    
To test for the presence of functional ASICs we carried out whole-cell patch-clamp recordings 
from  undifferentiated TEU-2 cells and from cultured human UE cells (two independent UE 
preparations). In both cell systems, a short (2.5-5 s) extracellular acidification from pH 7.4 to pH 
6 induced an inward current composed of a fast transient component and sustained component 
of variable amplitude (Fig.5A and 5B). The ASIC/ENaC blocker amiloride at 200 µM reversibly 
inhibited the transient, but not the sustained inward current (Fig.5A, summarized in Fig. 5D). 
The pH dependence of the ASIC currents was measured from the peak current amplitude in 
response to pH changes from pH 7.4 to different values, as illustrated by representative traces in 
Fig. 5B. The normalized current amplitude is plotted as a function of the stimulation pH in Fig. 
5C. To correct for the current rundown observed with repetitive stimulation, the measured 
amplitudes were normalized to the amplitudes of pH 6.5 reference responses measured between 
test stimulations. Fitting of the data to the Hill equation (Material and Methods) yielded a pH of 
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half-maximal activation (and Hill number) of 6.56 ± 0.01 (nH=4.14 ± 0.36, n=6) and 6.52 ± 0.03 
(nH=3.15 ± 1.19, n=10) for TEU-2 and UE cells respectively (Fig 5C), suggesting that this current 
is likely mediated by ASICs composed of subunits other than ASIC2. The pH6-induced 
amiloride-sensitive peak current density was -4.5 ± 1.0 (n=8) and -1.36 ± 0.27 pA/pF (n=13) in 
TEU-2 and UE cells, respectively. The pH6-evoked amiloride-sensitive inward currents 
inactivated with a time constant τ Ι=1.1 ± 0.1 (n=8) and 1.2 ± 0.2 s (n=8) for TEU-2 and UE cells 
respectively.  
Although we detected TRPV1 mRNA in TEU-2 cells using QPCR, perfusion of 1-10 µM 
capsaicin, a potent TRPV1 activator, did not elicit measurable inward currents in 
undifferentiated TEU-2 cells (n=9) nor in UE cells (n=14) (data not shown), suggesting that the 
observed low pH-evoked sustained current is not mediated by TRPV1. Using primers specific for 
TRPV1 exon 7 we were able to differentiate the expression of the full-length capsaicin-sensitive 
TRPV1 channel and its truncated dominant-negative isoform TRPV1b25 in TEU-2 cells. We show 
that in contrast to bladder tissue, TEU-2 cells express approximately 5-fold excess of TRPV1b 
(Fig. 6). 
Changes of ASICs and TRPV1 mRNA expression levels in BPS patients 
We investigated the mRNA levels of ASICs and TRPV1 in bladder biopsies of 28 patients compared to 
8 controls. Using QPCR we show that ASIC2a, and -3 were significantly (p<0.05) up-regulated in BPS 
patients compared to controls (Fig. 7A). No differences were found in ASIC1a mRNA levels (Fig. 7A). 
In contrast, TRPV1 mRNA was significantly (p<0.05) down-regulated in BPS patients (Fig 7B). 
 
DISCUSSION 
Tissue acidosis is a common feature of inflammatory and ischemic conditions, and there are indications 
for roles of ASICs and TRPV1 in pain sensation. We investigated the localization of ASIC isoforms 
in the human urinary bladder using QPCR and for ASIC1 by immunofluorescence. After a careful 
separation of the urothelium from the underlying tissue, we showed that all 3 investigated types of 
ASIC mRNA were detectable in both bladder layers, but there were differences in their amount and 
distribution. We showed that ASIC1a mRNA levels were significantly higher in sub-urothelial stroma 
than in purified urothelium. These observations were confirmed by immunofluorescence labeling, 
showing a strong ASIC1 antibody staining of the detrusor and vascular smooth muscle. In the isolated 
urothelium the mRNA levels of ASIC3 were significantly higher than ASIC1a, and ASIC2a was the 
least abundant mRNA as judged by QPCR. 
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To further characterize ASIC expression and function we used the urothelial cell line TEU-2. ASIC2a 
and ASIC3 mRNA levels significantly increased, whereas ASIC1a mRNA levels decreased during 
TEU-2 differentiation. Electrophysiological measurements showed that both the primary cultures of 
human urothelium and TEU-2 cells express functional ASICs, supporting our gene expression 
studies. In contrast, perfusion with capsaicin failed to elicit measurable currents, indicating the lack of 
functional TRPV1 channels in TEU-2 cells and primary UE cultures. Analysis of TRPV1 isoforms 
revealed a significant excess of the dominant-negative TRPV1b mRNA over the full-length 
TRPV1. The high abundance of this capsaicin-insensitive isoform 25 might explain the lack of 
TRPV1-mediated currents in these cells.  
We analyzed the levels of mRNAs encoding ASICs and TRPV1 in the cold-cut biopsies of human BPS 
patients, and showed a significant up-regulation of ASIC2a and -3, but not ASIC1a, in the BPS 
compared to the controls. In contrast to ASICs, the mRNA levels of TRPV1 were significantly lower in 
PBS patients compared to controls. TRPV1 localization has been well studied in bladder 18, and it has 
been implicated in generating the high frequency bladder reflex contractions 26, and mediating the 
bladder hyperactivity and noxious input induced by cystitis in mice 27. It is possible that the expression 
of ASICs and TRPV1 in peripheral tissues is differentially regulated during BPS, accounting for the 
observed decrease of TRPV1 mRNA levels. Interestingly, a similar down-regulation of TRPV1 has 
been recently observed in urothelial cancer 28. The biopsy collection protocol did not allow enough 
material to estimate the ASIC protein levels in BPS patients, which is a limitation of this study. 
Our ASIC data are in a good agreement with a recently published study, examining expression levels of 
these channels in the bladders of CYP-treated rats, where the acute and chronic administration of CYP 
increased ASIC2a and -3 mRNA levels up to 6-fold in bladder urothelium, but not in detrusor 13. 
Similar to our results, no up-regulation of ASIC1 was detected in rats 13. In a separate study of an 
inflammatory muscle injury in mice, ASIC2 and -3 mRNAs were elevated, but ASIC1 remained 
unchanged 29.  Therefore, an up-regulation of ASIC2a and -3 in BPS, reported here at the mRNA level 
in the human patients, and previously in animal models, might represent a general adaptive mechanism 
contributing to the increased pain responses. ASIC3 has been implicated in sensing prolonged 
acidification, and would therefore be a suitable candidate for the role of acidification sensor in bladder 
urothelium. Our results demonstrate a differential regulation of ASIC isoforms in the human bladder 
layers, which might contribute to the pain perception during BPS.  
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CONCLUSIONS 
Our study is the first to address the potential involvement of ASICs in BPS in humans. We show that 
ASICs are present in human bladder urothelium and smooth muscle. There is a significant down-
regulation of TRPV1, and up-regulation of mRNA levels of ASIC2a and ASIC3 in BPS patients 
compared to the controls. The up-regulation of ASICs in BPS might contribute to the bladder pain 
experienced in this condition.  
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Table 1 
 
 ASIC1a ASIC2a ASIC3 
isolated urothelium (n=4) 25.3 ± 0.82 * 
 
29.9 ± 0.4 * 
 
20.4 ± 0.79 * 
 
stroma (n=4) 21.48 ± 0.52 
 
29.3 ± 0.76 * 
 
19.12 ± 0.43 
 
UE cultures (n=3) 21.87 ± 0.42 
 
31.9 ± 0.44  * 
 
23.4 ± 0.75 
 
SM cultures (n=3) 21.5 ± 0.49  * 
 
32.11± 0.18  * 
 
24.5 ± 0.19  * 
 
TEU-2 monolayer (n=6) 21.57 ± 0.31  * 
 
31.36 ± 0.15  * 
 
23.48 ± 0.05  * 
 
TEU-2 multilayer  
(72h differentiation) (n=6) 
22.4 ± 0.10  * 
 
28.4 ± 0.32  * 
 
19.69 ± 0.27  * 
 
 
Table 1. Normalized expression values (ΔCt values) of ASICs in human bladder, cultured UE 
and bladder SM cells and TEU-2 cell line. 
Average Ct values detected in QPCR reactions of endogenous control (28S rRNA) were subtracted 
from the Ct values obtained during amplification of ASIC cDNA to obtain ΔCt ± SEM. ΔCt values are 
inversely proportional to the amount of template, i.e. a higher ΔCt value indicates a lower amount of 
the target cDNA. Statistically significant differences in the expression levels of an individual ASIC 
compared to all the other studied ASICs in the same sample are indicated (*p<0.05). 
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FIGURE LEGENDS 
 
Figure 1. Purity evaluation of bladder urothelium, separated by dispase II treatment  
Urothelium was separated from the underlying stroma in samples of normal human bladder 
(n=4), and mRNA levels of UE and SM-specific markers determined by TaqMan QPCR. (A) The 
results were normalized to 18S rRNA and expressed as fold difference relative to the average 
value for the bladder samples. (B) End-point PCR amplification of 18S, SM22 and UP2 in 
representative samples: Bl = bladder, UE = dispase-dissociated urothelium, Str = stroma.  
Figure 2. Quantitative evaluation of mRNA levels of ASIC1a, -2a and -3 in human bladder layers 
and in urothelial and smooth muscle cell cultures  
(A) Urothelium (UE) was separated from the underlying stroma in samples of normal human bladder 
(n=4), and mRNA levels of ASIC1a, -2a and -3 were determined by SYBR QPCR using specific 
primer pairs and were normalized to 28S rRNA. The data are expressed as fold difference relative to 
the average value for the stroma. Statistically significant differences between the bladder layers are 
indicated (*p<0.05).  
(B) Primary cultures of bladder smooth muscle (SMC) and urothelium (UEC) (n=3 each) were 
analyzed for the presence and quantity of ASIC mRNA using QPCR. The results were normalized to 
28S rRNA and expressed as fold difference relative to the average value for the smooth muscle culture. 
Figure 3. Immunofluorescence detection of ASIC1 in human bladder 
Ultrathin sections of the bladder dome obtained from 4 subjects were double labeled with anti-SM α-
actin monoclonal antibody (green) to localize the sub-urothelial muscle layer, and anti-ASIC1 
polyclonal antibody (Red). Nuclei were stained with DAPI. Representative images of urothelium (top 
panel) and smooth muscle (bottom panel) are shown.  
Figure 4. TEU-2 up-regulate ASIC2a and ASIC3 during differentiation 
(A) TEU-2 cells were grown on glass coverslips and stained with anti-occludin antibody (Invitrogen). 
Nuclei were visualized with DAPI. Upper panel – monolayer cultures of undifferentiated TEU-2; lower 
panel: TEU-2 after 72 h in differentiation medium 
(B) mRNA levels of ASIC1a, -2a and -3 were determined by QPCR in undifferentiated TEU-2 
monolayers, and 24 h, 48 h and 72 h after inducing differentiation. The results were normalized to 28S 
rRNA and expressed as fold difference relative to the average value for monolayer cultures. The graphs 
show an average of 3 experiments ± SEM. Statistically significant differences with the undifferentiated 
cells are indicated (*p<0.05). 
Figure 5. TEU-2 and human cultured urothelium cells express functional ASICs  
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Proton-induced currents were measured by whole-cell voltage-clamp to -60 mV from 
undifferentiated TEU-2 cells and from cultured human urothelium cells. The measured 
urothelium cells were in contact with neighboring cells because they grow in clusters. (A) 
Representative traces from TEU-2 cells (left panel) or UE cells (right panel) which were 
subjected to a rapid pH change from pH 7.4 to pH 6.0 with or without 200 µM amiloride for 5 s 
and 2.5 s respectively. For TEU-2 cells, the grey trace represents the amiloride-sensitive current 
component.  (B) Representative traces of acid-evoked currents at different pH from a holding pH 
of 7.4 are shown for TEU-2 (left panel) and UE cells (right panel). (C) Peak current amplitudes 
were normalized for each cell to the current obtained at pH 6.0 and plotted as a function of the 
test pH. Dashed curves represent the fit of the data points to the Hill equation, n = 6-10. (D) The 
peak inward current inhibition by 200 µM amiloride is shown for TEU-2 (hatched bars) and UE 
(filled bars)  n=8-10.  
 
Figure 6. TEU-2 cells preferentially express the TRPV1b isoform 
Samples of TEU-2 monolayer cultures (n=5) and total bladder (n= 3) were analyzed for the 
mRNA levels of TRPV1 using the long isoform-specific primers, and the TRPV1+1b non-
discriminating primer pair. The results are shown as fold difference relative to the total 
TRPV1+1b amount  ± SEM (**p<0.005).   
 
Figure 7. mRNA levels of ASIC1a, -2a, -3 and TRPV1 in BPS patients 
(A) The mRNA levels of ASIC1a, -2a and -3 in dome biopsies of 8 healthy controls, and 28 patients 
with BPS were determined by SYBR Green Real-time RT-PCR, normalized to 28S RNA and 
expressed relative to control averages. The graph shows the average for ASIC expression in bladder 
dome biopsies ± SEM (n=8 for control group; n=28 for BPS group). ASIC2a and ASIC3 mRNA levels 
are significantly (*p<0.05) up-regulated in BPS patients compared to controls. The mRNA levels of 
ASIC1a did not change between the two groups.  
(B) mRNA levels of TRPV1 were determined by TaqMan QPCR using the TRPV1 + 1b non-
discriminating primer pair. TRPV1 is significantly (*p<0.05) down-regulated in BPS patients (n=28) 
compared to controls (n=8).  
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